What does CUSIP G1933S101 represent in this 13F holders report?

CUSIP G1933S101 is the security identifier for CASIF - CASI Pharmaceuticals, Inc. - Ordinary Shares used to aggregate holder disclosures.

How many institutions held CASIF - CASI Pharmaceuticals, Inc. - Ordinary Shares in Q4 2022?

1 institutional investor reported CASIF - CASI Pharmaceuticals, Inc. - Ordinary Shares for Q4 2022. Use the holders table for investor-level position and value details.

CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF)

CUSIP: G1933S101

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / Ordinary Shares
Shares outstanding: 35,821,764
Total 13F shares: 100
Share change: +100
Total reported value: $179
Price per share: $1.79
Number of holders: 1
Value change: +$179
Number of buys: 1

Quarterly Holders Quick Answers

What is CUSIP G1933S101?
CUSIP G1933S101 identifies CASIF - CASI Pharmaceuticals, Inc. - Ordinary Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2023

Recent filing periods for CUSIP G1933S101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CASIF - CASI Pharmaceuticals, Inc. - Ordinary Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FEDERATED HERMES, INC.	13F	Company	— class O/S missing	1,015,000	$2,639,000	—	30 Sep 2022	13F
VANGUARD GROUP INC	13F	Company	— class O/S missing	257,443	$669,000	—	30 Sep 2022	13F
Wellington Shields Capital Management, LLC	13F	Company	— class O/S missing	218,247	$567,000	—	30 Sep 2022	13F
Wellington Shields & Co., LLC	13F	Company	— class O/S missing	145,315	$378,000	—	30 Sep 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	98,308	$255,000	—	30 Sep 2022	13F
BlackRock Finance, Inc.	13F	Company	— class O/S missing	91,714	$239,000	—	30 Sep 2022	13F
STATE STREET CORP	13F	Company	— class O/S missing	35,555	$92,000	—	30 Sep 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	— class O/S missing	33,637	$87,000	—	30 Sep 2022	13F
NORTHERN TRUST CORP	13F	Company	— class O/S missing	25,593	$67,000	—	30 Sep 2022	13F
FRANKLIN RESOURCES INC	13F	Company	— class O/S missing	24,546	$64,000	—	30 Sep 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	— class O/S missing	11,508	$30,000	—	30 Sep 2022	13F
PRUDENTIAL FINANCIAL INC	13F	Company	— class O/S missing	11,000	$29,000	—	30 Sep 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	— class O/S missing	10,400	$27,000	—	30 Sep 2022	13F
MORGAN STANLEY	13F	Company	— class O/S missing	3,797	$10,000	—	30 Sep 2022	13F
UBS Group AG	13F	Company	— class O/S missing	3,089	$8,000	—	30 Sep 2022	13F
Tower Research Capital LLC (TRC)	13F	Company	— class O/S missing	2,187	$6,000	—	30 Sep 2022	13F
OSAIC HOLDINGS, INC.	13F	Company	— class O/S missing	200	$1,000	—	30 Sep 2022	13F
IFP Advisors, Inc	13F	Company	— class O/S missing	9	$1,000	—	30 Sep 2022	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	— class O/S missing	134	$348	—	30 Sep 2022	13F

Institutional Holders of CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF) as of Q4 2022

As of 31 Dec 2022, CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 100 shares. The largest 1 holders included WEST PACES ADVISORS INC.. This page lists 1 institutional shareholders reporting positions in this security for the Q4 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2022 vs Q4 2025 Across Filers

Q4 2025 holders

Q4 2022 holders

Holder diff

-15

Investor	Q4 2025 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q4 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.